Arrowstreet Capital Limited Partnership increased its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 188.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 417,515 shares of the financial services provider’s stock after acquiring an additional 272,619 shares during the quarter. Arrowstreet Capital Limited Partnership owned approximately 0.06% of MetLife worth $33,577,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Delta Investment Management LLC raised its stake in MetLife by 0.9% during the first quarter. Delta Investment Management LLC now owns 14,265 shares of the financial services provider’s stock worth $1,145,000 after purchasing an additional 133 shares during the period. Ignite Planners LLC increased its holdings in shares of MetLife by 2.2% during the 2nd quarter. Ignite Planners LLC now owns 6,366 shares of the financial services provider’s stock worth $491,000 after buying an additional 136 shares during the last quarter. Legacy Capital Wealth Partners LLC raised its position in shares of MetLife by 3.2% during the 2nd quarter. Legacy Capital Wealth Partners LLC now owns 4,355 shares of the financial services provider’s stock valued at $350,000 after buying an additional 137 shares during the period. Glenview Trust co lifted its holdings in MetLife by 0.4% in the first quarter. Glenview Trust co now owns 38,333 shares of the financial services provider’s stock valued at $3,078,000 after acquiring an additional 141 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. grew its position in MetLife by 1.0% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 14,902 shares of the financial services provider’s stock worth $1,198,000 after acquiring an additional 148 shares during the period. 94.99% of the stock is currently owned by institutional investors and hedge funds.
MetLife Price Performance
Shares of MET opened at $78.60 on Friday. The company has a quick ratio of 0.18, a current ratio of 0.18 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $88.09. The company has a market cap of $51.79 billion, a P/E ratio of 14.80, a PEG ratio of 0.75 and a beta of 0.76. The firm’s 50 day moving average price is $78.67 and its 200 day moving average price is $78.69.
MetLife Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 4th will be issued a dividend of $0.5675 per share. The ex-dividend date is Tuesday, November 4th. This represents a $2.27 annualized dividend and a yield of 2.9%. MetLife’s dividend payout ratio is 42.75%.
Analyst Upgrades and Downgrades
Several equities analysts have recently commented on the company. Morgan Stanley upped their price target on MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Wolfe Research upgraded shares of MetLife to a “strong-buy” rating in a report on Tuesday, September 16th. Jefferies Financial Group increased their target price on shares of MetLife from $100.00 to $103.00 and gave the stock a “buy” rating in a research note on Monday, August 11th. Weiss Ratings downgraded shares of MetLife from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday. Finally, Barclays increased their price objective on shares of MetLife from $93.00 to $98.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $94.60.
View Our Latest Analysis on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- Stock Splits, Do They Really Impact Investors?
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- How to Plot Fibonacci Price Inflection Levels
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
- Stock Sentiment Analysis: How it Works
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
